99 related articles for article (PubMed ID: 38768405)
21. State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation.
Pathak PS; Chan G; Deming DA; Chee CE
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e438466. PubMed ID: 38768405
[TBL] [Abstract][Full Text] [Related]
22. Precision medicine for metastatic colorectal cancer: an evolving era.
Guler I; Askan G; Klostergaard J; Sahin IH
Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):919-931. PubMed ID: 31475851
[No Abstract] [Full Text] [Related]
23. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
Lin PS; Semrad TJ
Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
[TBL] [Abstract][Full Text] [Related]
24. From tumour heterogeneity to advances in precision treatment of colorectal cancer.
Punt CJ; Koopman M; Vermeulen L
Nat Rev Clin Oncol; 2017 Apr; 14(4):235-246. PubMed ID: 27922044
[TBL] [Abstract][Full Text] [Related]
25. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Coppedè F; Lopomo A; Spisni R; Migliore L
World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
[TBL] [Abstract][Full Text] [Related]
26. Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer.
Piawah S; Venook AP
Cancer; 2019 Dec; 125(23):4139-4147. PubMed ID: 31433498
[TBL] [Abstract][Full Text] [Related]
27. Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.
Atreya CE; Yaeger R; Chu E
Am Soc Clin Oncol Educ Book; 2017; 37():246-256. PubMed ID: 28561718
[TBL] [Abstract][Full Text] [Related]
28. Current and evolving biomarkers for precision oncology in the management of metastatic colorectal cancer.
Henry JT; Johnson B
Chin Clin Oncol; 2019 Oct; 8(5):49. PubMed ID: 31500426
[TBL] [Abstract][Full Text] [Related]
29. Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision.
Rebersek M
Radiol Oncol; 2020 May; 54(3):272-277. PubMed ID: 32463385
[TBL] [Abstract][Full Text] [Related]
30. Biomarker-guided therapy for colorectal cancer: strength in complexity.
Sveen A; Kopetz S; Lothe RA
Nat Rev Clin Oncol; 2020 Jan; 17(1):11-32. PubMed ID: 31289352
[TBL] [Abstract][Full Text] [Related]
31. Molecular Profiling in Metastatic Colorectal Cancer.
Armstrong SA; Malley R; Weinberg BA
Oncology (Williston Park); 2020 Sep; 34(9):352-355. PubMed ID: 32965665
[TBL] [Abstract][Full Text] [Related]
32. Chasing the personalized medicine dream through biomarker validation in colorectal cancer.
Patil H; Saxena SG; Barrow CJ; Kanwar JR; Kapat A; Kanwar RK
Drug Discov Today; 2017 Jan; 22(1):111-119. PubMed ID: 27693431
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer.
Baek SK; Lee KT; Bae SB; Lee SC
Korean J Intern Med; 2019 Nov; 34(6):1188-1196. PubMed ID: 31346151
[TBL] [Abstract][Full Text] [Related]
34. Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies.
Akkad J; Bochum S; Martens UM
Langenbecks Arch Surg; 2015 Feb; 400(2):129-43. PubMed ID: 25701352
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
[TBL] [Abstract][Full Text] [Related]
36. Colorectal cancer: from prevention to personalized medicine.
Binefa G; RodrÃguez-Moranta F; Teule A; Medina-Hayas M
World J Gastroenterol; 2014 Jun; 20(22):6786-808. PubMed ID: 24944469
[TBL] [Abstract][Full Text] [Related]
37. Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine.
Mouillet-Richard S; Cazelles A; Sroussi M; Gallois C; Taieb J; Laurent-Puig P
Clin Cancer Res; 2024 Jun; 30(11):2351-2358. PubMed ID: 38564259
[TBL] [Abstract][Full Text] [Related]
38. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.
Mohapatra SS; Batra SK; Bharadwaj S; Bouvet M; Cosman B; Goel A; Jogunoori W; Kelley MJ; Mishra L; Mishra B; Mohapatra S; Patel B; Pisegna JR; Raufman JP; Rao S; Roy H; Scheuner M; Singh S; Vidyarthi G; White J
Dig Dis Sci; 2018 May; 63(5):1123-1138. PubMed ID: 29572615
[TBL] [Abstract][Full Text] [Related]
39. Cancer Stem Cells and Molecular Biology Test in Colorectal Cancer: Therapeutic Implications.
Effendi-Ys R
Acta Med Indones; 2017 Oct; 49(4):351-359. PubMed ID: 29348387
[TBL] [Abstract][Full Text] [Related]
40. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.
Wang W; Kandimalla R; Huang H; Zhu L; Li Y; Gao F; Goel A; Wang X
Semin Cancer Biol; 2019 Apr; 55():37-52. PubMed ID: 29775690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
